iSpecimen Inc. Payments for Rent
iSpecimen Inc. (ISPC) reported Payments for Rent of $85.51 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-01.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRent · last filed 2026-04-01
- iSpecimen Inc. payments for rent for the quarter ending 2025-12-31 was $23.92K, a 34.45% decline year-over-year.
- iSpecimen Inc. payments for rent for the quarter ending 2025-09-30 was $20.53K, a 27.88% decline year-over-year.
- iSpecimen Inc. payments for rent for the quarter ending 2025-06-30 was $20.53K, a 57.56% decline year-over-year.
- iSpecimen Inc. payments for rent for the quarter ending 2025-03-31 was $20.53K, a 52.53% decline year-over-year.
- iSpecimen Inc. payments for rent for fiscal 2025 was $85.51K, a 45.39% decline from fiscal 2024.
- iSpecimen Inc. payments for rent for fiscal 2024 was $156.59K, a 7.33% decline from fiscal 2023.
- iSpecimen Inc. payments for rent for fiscal 2023 was $168.99K.
| Period end | Payments for Rent 3 month | Payments for Rent 6 month | Payments for Rent 9 month | Payments for Rent 12 month |
|---|---|---|---|---|
| 2025-12-31 | $23.92K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $44.45K derived: sum of 2 quarters · filed 2026-04-01 | $64.98K derived: sum of 3 quarters · filed 2026-04-01 | $85.51K 10-K · filed 2026-04-01 |
| 2025-09-30 | $20.53K 10-Q · filed 2025-11-17 | $41.06K derived: sum of 2 quarters · filed 2025-11-17 | $61.59K 10-Q · filed 2025-11-17 | $98.08K derived: sum of 4 quarters · filed 2026-04-01 |
| 2025-06-30 | $20.53K 10-Q · filed 2025-08-14 | $41.06K 10-Q · filed 2025-08-14 | $77.55K derived: sum of 3 quarters · filed 2026-04-01 | $106.02K derived: sum of 4 quarters · filed 2026-04-01 |
| 2025-03-31 | $20.53K 10-Q · filed 2025-05-19 | $57.02K derived: sum of 2 quarters · filed 2026-04-01 | $85.49K derived: sum of 3 quarters · filed 2026-04-01 | $133.87K derived: sum of 4 quarters · filed 2026-04-01 |
| 2024-12-31 | $36.49K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $64.96K derived: sum of 2 quarters · filed 2026-04-01 | $48.38K 10-Q · filed 2025-08-14 | $156.59K 10-K · filed 2026-04-01 |
| 2024-09-30 | $28.47K 10-Q · filed 2025-11-17 | $76.85K derived: sum of 2 quarters · filed 2025-11-17 | $120.10K 10-Q · filed 2025-11-17 | $163.35K derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | $48.38K 10-Q · filed 2024-08-06 | $91.63K 10-Q · filed 2025-08-14 | $134.88K derived: sum of 3 quarters · filed 2025-05-19 | $175.96K derived: sum of 4 quarters · filed 2025-05-19 |
| 2024-03-31 | $43.25K 10-Q · filed 2025-05-19 | $86.50K derived: sum of 2 quarters · filed 2025-05-19 | $127.58K derived: sum of 3 quarters · filed 2025-05-19 | $169.66K derived: sum of 4 quarters · filed 2025-05-19 |
| 2023-12-31 | $43.25K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-14 | $84.33K derived: sum of 2 quarters · filed 2025-04-14 | $126.41K derived: sum of 3 quarters · filed 2025-04-14 | $168.99K 10-K · filed 2025-04-14 |
| 2023-09-30 | $41.08K 10-Q · filed 2024-11-07 | $83.16K derived: sum of 2 quarters · filed 2024-11-07 | $125.73K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $42.08K 10-Q · filed 2024-08-06 | $84.66K 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | $42.58K 10-Q · filed 2024-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |